PharmaEngine, the Asia-Pacific partner of Nanobiotix (Euronext:Nano), has dosed its first patient in a new Phase I/II trial in patients…
PharmaEngine, the Asia-Pacific partner of Nanobiotix (Euronext:Nano), has dosed its first patient in a new Phase I/II trial in patients…